Yvan Samson

2.8k total citations
30 papers, 1.9k citations indexed

About

Yvan Samson is a scholar working on Pediatrics, Perinatology and Child Health, Neurology and Genetics. According to data from OpenAlex, Yvan Samson has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pediatrics, Perinatology and Child Health, 10 papers in Neurology and 7 papers in Genetics. Recurrent topics in Yvan Samson's work include Childhood Cancer Survivors' Quality of Life (10 papers), Neuroblastoma Research and Treatments (8 papers) and Glioma Diagnosis and Treatment (7 papers). Yvan Samson is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (10 papers), Neuroblastoma Research and Treatments (8 papers) and Glioma Diagnosis and Treatment (7 papers). Yvan Samson collaborates with scholars based in Canada, United States and Puerto Rico. Yvan Samson's co-authors include Stephen E. Sallan, Luis A. Clavell, Marshall A. Schorin, Barbara L. Asselin, Albert Moghrabi, Lewis B. Silverman, Steven E. Lipshultz, Ronald D. Barr, Craig A. Hurwitz and Richard D. Gelber and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Oncology.

In The Last Decade

Yvan Samson

30 papers receiving 1.8k citations

Peers

Yvan Samson
Virginia Dalton United States
Karsten Nysom Denmark
Donna E. Levy United States
Elly Barry United States
Doojduen Villaluna United States
Gill Levitt United Kingdom
Anne Uyttebroeck Belgium
Jos P.M. Bökkerink Netherlands
Kerri Nottage United States
Alexander Fosså Norway
Virginia Dalton United States
Yvan Samson
Citations per year, relative to Yvan Samson Yvan Samson (= 1×) peers Virginia Dalton

Countries citing papers authored by Yvan Samson

Since Specialization
Citations

This map shows the geographic impact of Yvan Samson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvan Samson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvan Samson more than expected).

Fields of papers citing papers by Yvan Samson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvan Samson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvan Samson. The network helps show where Yvan Samson may publish in the future.

Co-authorship network of co-authors of Yvan Samson

This figure shows the co-authorship network connecting the top 25 collaborators of Yvan Samson. A scholar is included among the top collaborators of Yvan Samson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvan Samson. Yvan Samson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Loeb, David M., Ji Won Lee, Daniel A. Morgenstern, et al.. (2022). Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial. Cancer Immunology Immunotherapy. 71(10). 2485–2495. 13 indexed citations
2.
Ospina, Luis H., et al.. (2019). Central and peripheral steady-state visual evoked potentials in children with optic pathway gliomas. Documenta Ophthalmologica. 139(2). 137–149. 1 indexed citations
3.
Johnston, Donna L., Daniel A. Morgenstern, Aru Narendran, et al.. (2019). Phase I dose‐finding study for melatonin in pediatric oncology patients with relapsed solid tumors. Pediatric Blood & Cancer. 66(6). e27676–e27676. 7 indexed citations
4.
Johnston, Donna L., Daniel A. Morgenstern, Aru Narendran, et al.. (2018). Phase I dose finding study for melatonin in paediatric oncology patients with relapsed solid tumors.. Journal of Clinical Oncology. 36(15_suppl). e22514–e22514. 1 indexed citations
5.
Samson, Yvan, et al.. (2017). Clinical Presentation and Outcome of Patients With Optic Pathway Glioma. Pediatric Neurology. 75. 55–60. 34 indexed citations
6.
7.
Guilbert, Marie‐Christine, Anne‐Laure Rougemont, Yvan Samson, et al.. (2014). Transformation of a Primitive Myxoid Mesenchymal Tumor of Infancy to an Undifferentiated Sarcoma. Journal of Pediatric Hematology/Oncology. 37(2). e118–e120. 9 indexed citations
8.
Bouffet, Éric, Diana Stempak, Janet Gammon, et al.. (2010). A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. European Journal of Cancer. 46(18). 3271–3279. 34 indexed citations
9.
Lipshultz, Steven E., Rebecca E. Scully, Stuart R. Lipsitz, et al.. (2010). Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial. The Lancet Oncology. 11(10). 950–961. 317 indexed citations
10.
Dugas, Marc-André, et al.. (2009). Do Children Undergoing Cancer Procedures under Pharmacological Sedation Still Report Pain and Anxiety? A Preliminary Study. Pain Medicine. 11(2). 215–223. 17 indexed citations
11.
Barry, Elly, Lynda M. Vrooman, Suzanne E. Dahlberg, et al.. (2008). Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane. Journal of Clinical Oncology. 26(7). 1106–1111. 89 indexed citations
12.
Barrette, Stéphane, Mark L. Bernstein, Leslie L. Robison, et al.. (2007). Incidence of Neuroblastoma After a Screening Program. Journal of Clinical Oncology. 25(31). 4929–4932. 7 indexed citations
13.
Hukin, Juliette, Paul Steinbok, Lucie Lafay‐Cousin, et al.. (2007). Intracystic bleomycin therapy for craniopharyngioma in children. Cancer. 109(10). 2124–2131. 62 indexed citations
14.
Barry, Elly, Daniel J. DeAngelo, Donna Neuberg, et al.. (2007). Favorable Outcome for Adolescents With Acute Lymphoblastic Leukemia Treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols. Journal of Clinical Oncology. 25(7). 813–819. 137 indexed citations
15.
Lipshultz, Steven E., Stuart R. Lipsitz, Rebecca E. Scully, et al.. (2007). Abstract 2550: N-terminal Pro-brain Natriuretic Peptide-defined Cardiomyopathy in Doxorubicin-treated Children with Acute Lymphoblastic Leukemia. Circulation. 116(suppl_16). 1 indexed citations
16.
Tabori, Uri, Lillian Sung, Juliette Hukin, et al.. (2005). Medulloblastoma in the second decade of life: A specific group with respect to toxicity and management. Cancer. 103(9). 1874–1880. 48 indexed citations
17.
Tabori, Uri, Lillian Sung, Juliette Hukin, et al.. (2005). Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. International Journal of Radiation Oncology*Biology*Physics. 64(2). 402–407. 25 indexed citations
18.
Lipshultz, Steven E., Nader Rifai, Virginia Dalton, et al.. (2004). The Effect of Dexrazoxane on Myocardial Injury in Doxorubicin-Treated Children with Acute Lymphoblastic Leukemia. New England Journal of Medicine. 351(2). 145–153. 422 indexed citations
19.
Lipshultz, Steven E., Stuart R. Lipsitz, Virginia Kimball Dalton, et al.. (2002). Doxorubicin Administration by Continuous Infusion Is Not Cardioprotective: The Dana-Farber 91-01 Acute Lymphoblastic Leukemia Protocol. Journal of Clinical Oncology. 20(6). 1677–1682. 91 indexed citations
20.
Loh, Mignon L., et al.. (2000). Translocation (2;8)(p12;q24) associated with a cryptic t(12;21)(p13;q22) TEL/AML1 gene rearrangement in a child with acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 122(2). 79–82. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virginia Dalton Breakdown of academic impact, for papers by Karsten Nysom Breakdown of academic impact, for papers by Donna E. Levy Breakdown of academic impact, for papers by Elly Barry Breakdown of academic impact, for papers by Doojduen Villaluna Breakdown of academic impact, for papers by Gill Levitt Breakdown of academic impact, for papers by Anne Uyttebroeck Breakdown of academic impact, for papers by Jos P.M. Bökkerink Breakdown of academic impact, for papers by Kerri Nottage Breakdown of academic impact, for papers by Alexander Fosså
Rankless by CCL
2026